Newsletter | May 22, 2026

05.22.26 -- Reimagine Data Governance For The AI Era

SPONSOR

Reducing Avoidable Protocol Amendments By Anticipating Operational Pitfalls Hidden In Clinical Trial Design

Protocol amendments are often treated as inevitable, yet operational trial data reveals that many follow predictable patterns tied to early study design decisions.  Learn how amendment drivers vary across therapeutic areas and how those changes impact execution, patient burden, site workload, timelines, and study costs.

TRIAL MONITORING

Pick The Right PV Technology With Help From A Safety Data Management Expert

From The Editor | A conversation between Clinical Leader Executive Editor Abby Proch and Vikalp Khare, Otsuka

Otsuka's Head of U.S. GPV Safety Data Management Vikalp Khare shares how smart governance should inform pharmacovigilance (PV) technology choices.

Practical ICH E6(R3) Oversight For Your Centralized Monitoring Strategy

Webinar | Castor

Bridge the gap between fragmented data and ICH E6(R3) compliance. Learn to use unified data signals to catch consent errors and enrollment delays before they trigger audit findings.

From Study Feasibility And Recruitment To Monitoring And Quality

Product | Southern Star Research

We specialize in providing flexible, high-quality, and custom solutions that help you deliver regulator-ready data on time and at a predictable price.

CLINICAL DATA MANAGEMENT & ANALYTICS

Reimagine Data Governance For The AI Era

Guest Column | By Partha Anbil & Partha Khot

Understand the persistent governance challenges that undermine AI initiatives and walk away with a robust blueprint for building a resilient, scalable, and ethically sound framework.

How Life Sciences Leaders Are Preparing For More Curveballs In 2026

Article | By Jim Ingram, Sikich

Anticipate regulatory shifts and supply chain hurdles with agile scenario planning. Move beyond fragmented systems to build a resilient, data-driven foundation for a volatile industry landscape.

Aligning Global Standards For ICH E6(R3) And Artificial Intelligence

Article | By Marc Wartenberger, CRIO

Global standards and AI are transforming clinical research. Learn why mastering ICH E6(R3) and risk-based compliance is critical for data integrity and future success.

Clinical Pharmacokinetics And Pharmacometrics

Brochure | CHDR

Learn about a sophisticated suite of pharmacokinetic (PK) and pharmacometric services designed to accelerate and optimize early-phase drug development.

Real-World Data And Real-World Evidence

Brochure | ISPOR—The Professional Society for Health Economics and Outcomes Research

As clinical research evolves, RWD and RWE play a crucial role in complementing conventional randomized controlled trials (RCTs) by capturing insights that accurately reflect clinical practice.

CHOOSE YOUR OWN ADVENTURE

You're receiving the Friday edition of the Clinical Leader newsletter, focusing on Clinical Data Management & Analytics and Trial Monitoring. To make changes to your newsletter selections, update your topic preferences.

  • Clinical Sites | Patient Centricity | Patient Recruitment (Monday)
  • Clinical Trial Technology (Tuesday)
  • Decentralized Trials | Trial Management (Wednesday)
  • Outsourcing Models | Regulatory & Compliance (Thursday)
  • Clinical Data Management & Analytics | Trial Monitoring (Friday)

Learn more about our personalized newsletters here.

Connect With Clinical Leader: